JIANG ZHONG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.77 CNY | -0.34% |
|
-4.22% | +28.21% |
| Mar. 22 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | GuangYuYuan Makes Leadership Reshuffle | MT |
ETFs positioned on Jiang Zhong Pharmaceutical Co.,Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 4 M€ | -2.96% |
JIANGZHONG PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the manufacture, research and development and sales of over-the-counter (OTC) pharmaceuticals and healthcare products. The Companyâs products include OTC medicines, healthcare products and functional food, as well as wine. Its OTC pharmaceuticals include indigestion tablets, lactobacillin tablets and sarcandra glabra tablets, among others. Its healthcare products and functional food include calcium tablets and ginseng products, among others. The Company mainly operates its businesses in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.77
CNY
Average target price
31.12
CNY
Spread / Average Target
+16.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.21% | 2.3B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600750 Stock
- Funds and ETFs Jiang Zhong Pharmaceutical Co.,Ltd
